Human papillomavirus vaccine efficacy and effectiveness against cancer
S Kamolratanakul, P Pitisuttithum - Vaccines, 2021 - mdpi.com
Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …
Carcinogenic human papillomavirus infection
Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …
[HTML][HTML] Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices
E Meites - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Background HPV is a common sexually transmitted infection, with HPV acquisition generally
occurring soon after first sexual activity (1). Most HPV infections are transient and …
occurring soon after first sexual activity (1). Most HPV infections are transient and …
Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America
MA Thompson, MA Horberg, AL Agwu… - Clinical infectious …, 2021 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …
[HTML][HTML] HPV vaccines–a review of the first decade
DM Harper, LR DeMars - Gynecologic oncology, 2017 - Elsevier
Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)
LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
A review of clinical trials of human papillomavirus prophylactic vaccines
JT Schiller, X Castellsagué, SM Garland - Vaccine, 2012 - Elsevier
End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV)
virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct …
virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct …
Natural history of HPV infection across the lifespan: role of viral latency
PE Gravitt, RL Winer - Viruses, 2017 - mdpi.com
Large-scale epidemiologic studies have been invaluable for elaboration of the causal
relationship between persistent detection of genital human papillomavirus (HPV) infection …
relationship between persistent detection of genital human papillomavirus (HPV) infection …
Updates on HPV vaccination
O Illah, A Olaitan - Diagnostics, 2023 - mdpi.com
Cervical cancer still poses a significant global challenge. Developed countries have
mitigated this challenge by the introduction of structured screening programmes and, more …
mitigated this challenge by the introduction of structured screening programmes and, more …